Kidamycin
Chemical compound
From Wikipedia, the free encyclopedia
Kidamycin is an anthracycline antibiotic with anticancer activity.[1] It was first synthesized from a strain of streptomyces bacteria isolated from a soil sample.[2] In clinical trials, Kindamycin showed high effect against gram positive bacteria as well as multiple cancer models including Ehrlich ascites carcinoma, Sarcoma 180, NF-sarcoma, and Yoshida sarcoma.[3]
| Names | |
|---|---|
| Other names
Rubiflavin B | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| |
| |
| Properties | |
| C39H48N2O9 | |
| Molar mass | 688.818 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
